FUNCTION AND CONTROL OF OCT-2 EXPRESSION IN T LINEAGE CELLS

T 谱系细胞中 OCT-2 表达的功能和控制

基本信息

  • 批准号:
    3793632
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Regulatory gene hierarchies underlying the development of B and T cells from a presumptive lymphoid precursor are at present poorly defined. The Oct-2 gene encodes a developmental regulator of immunoglobulin gene transcription, and is likely to represent a member of a regulatory gene hierarchy responsible for B cell differentiation. The Oct-2 protein is a member of the POU box family of regulators and is a tissue specific transcription factor. Transient ectopic expression of Oct-2 in HeLa cell results in the activation of a co-transfected immunoglobulin promoter construct. In myeloma x fibroblast cell hybrids extinction of immunoglobulin gene expression correlates with loss of Oct-2 expression. The expression of Oct-2 is not exclusively restricted to cells of the B lineage. Oct-2 is expressed in some transformed T cell lines. We have found that the Oct-2 gene is expressed at low levels in resting T cell clones and the gene is up-regulated upon T cell activation by signalling through the T cell receptor. To date, no function for Oct-2 has been demonstrated in cells of the T lineage. The goal of this project is to investigate the function and regulation of Oct-2 during the development and maturation of T lymphocytes. The specific aims are to: 1) analyze the expression of Oct-2 during T cell development and functional maturation; 2) dissect the regulatory mechanism controlling Oct-2 expression during T cell activation including the characterization of regulatory elements in the Oct-2 gene that enable expression in T cells and responsiveness to external stimuli; 3) identify T cell target genes for Oct-2 by testing regulatory regions of cloned genes as well as by attempting to clone DNA segments which are specifically photochemically cross-linked with Oct-2 in vivo; 4)test the function of Oct-2 during T cell activation by blocking expression or' function with the use of anti-sense CDNA constructs or dominant negative Oct-2 mutants, respectively. This project will not only complement ongoing studies on Oct-2 in B lymphocytes, but will provide an excellent system for examining how a common tissue specific transcription factor functions in the regulatory networks of two distinct, but related cell lineages. Such an analysis will provide insight into molecular mechanisms controlling the normal and malignant development of lymphocytes.
B和T发育的调控基因层次 细胞 从一个假定的淋巴前体,目前尚不明确。 的 Oct-2基因编码免疫球蛋白基因的发育调节因子 转录,并且可能代表调控基因的成员 负责B细胞分化的层级。 Oct-2蛋白是一种 POU盒调节剂家族的成员,是组织特异性的 转录因子 Oct-2在HeLa细胞中的瞬时异位表达 导致共转染的免疫球蛋白启动子的激活 构建体 在骨髓瘤x成纤维细胞杂交中, 免疫球蛋白基因表达与Oct-2表达缺失相关。 Oct-2的表达不仅限于B细胞 脉 Oct-2在一些转化的T细胞系中表达。 我们有 发现Oct-2基因以低水平表达, 在静息T细胞中 克隆,该基因在T细胞活化时通过信号传导上调 通过T细胞受体。到目前为止,10月2日还没有任何功能, 在T细胞系中得到证实。该项目的目标是 探讨Oct-2在胚胎发育过程中的作用和调控 和T淋巴细胞的成熟。具体目的是:1)分析 Oct-2在T细胞发育和功能成熟过程中的表达; 2)剖析T细胞中控制Oct-2表达的调控机制, 细胞活化,包括表征 Oct-2基因能够在T细胞中表达并对 外部刺激; 3)通过测试鉴定Oct-2的T细胞靶基因 克隆基因的调控区,以及试图克隆 与特定光化学交联的DNA片段 Oct-2在体内的作用; 4)检测Oct-2在T细胞活化过程中的功能, 使用反义cDNA阻断表达或功能 构建体或显性失活Oct-2突变体。 这 该项目不仅将补充10月2日在B进行的研究 淋巴细胞,但将提供一个很好的系统,检查如何 常见的组织特异性转录因子在调节 两种不同但相关的细胞谱系的网络。这种分析 将提供深入了解分子机制控制正常和 淋巴细胞的恶性发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARINDER SINGH其他文献

HARINDER SINGH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARINDER SINGH', 18)}}的其他基金

Systems Biology Core
系统生物学核心
  • 批准号:
    10404142
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Systems Biology Core
系统生物学核心
  • 批准号:
    10705640
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
B cell population structure in mouse and man
小鼠和人的 B 细胞群结构
  • 批准号:
    10456757
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Molecular and Cellular Biology Training Grant
分子和细胞生物学培训补助金
  • 批准号:
    7246868
  • 财政年份:
    1975
  • 资助金额:
    --
  • 项目类别:
Molecular and Cellular Biology Training Grant
分子和细胞生物学培训补助金
  • 批准号:
    6898357
  • 财政年份:
    1975
  • 资助金额:
    --
  • 项目类别:
Molecular and Cellular Biology Training Grant
分子和细胞生物学培训补助金
  • 批准号:
    6763093
  • 财政年份:
    1975
  • 资助金额:
    --
  • 项目类别:
Molecular and Cellular Biology Training Grant
分子和细胞生物学培训补助金
  • 批准号:
    6498574
  • 财政年份:
    1975
  • 资助金额:
    --
  • 项目类别:
Molecular and Cellular Biology Training Grant
分子和细胞生物学培训补助金
  • 批准号:
    6628759
  • 财政年份:
    1975
  • 资助金额:
    --
  • 项目类别:
FUNCTION AND CONTROL OF OCT-2 EXPRESSION IN T LINEAGE CELLS
T 谱系细胞中 OCT-2 表达的功能和控制
  • 批准号:
    3805896
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
FUNCTION AND CONTROL OF OCT-2 EXPRESSION IN T LINEAGE CELLS
T 谱系细胞中 OCT-2 表达的功能和控制
  • 批准号:
    3771447
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了